Full text

Turn on search term navigation

© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Silver nanoparticles (AgNPs) are known and widely used for their antibacterial properties. However, the ever-increasing resistance of microorganisms compels the design of novel nanomaterials which are able to surpass their capabilities. Herein, we synthesized silver nanoparticles using, for the first time, polyhydroxy fullerene (PHF) as a reducing and capping agent, through a one-pot synthesis method. The resulting nanoparticles (PHF-AgNPs) were compared to AgNPs that were synthesized using sodium citrate (citrate-AgNPs). They were characterized using high-resolution transmission electron microscopy (HR-TEM), dynamic light scattering, and UV-visible spectroscopy. Our results showed that PHF-AgNPs have a smaller size and a narrower size distribution than citrate-AgNPs, which suggests that PHF may be a better capping agent than citrate. Antibacterial assays using E. coli showed enhanced antimicrobial activity for PHF-AgNPs compared to citrate-AgNPs. The electrocatalytic activity of nanoparticles towards oxygen evolution and reduction reaction (OER and ORR, respectively) was tested through cyclic voltammetry. Both nanoparticles are found to promote OER and ORR, but PHF-AgNPs showed a significant increase in activity with respect to citrate-AgNPs. Thus, our results demonstrate that the properties of forming nanoparticles can be tuned by choosing the appropriate reducing/capping agent. Specifically, this suggests that PHF-AgNPs can find potential applications for both catalytic and biomedical applications.

Details

Title
Polyhydroxy Fullerenes Enhance Antibacterial and Electrocatalytic Activity of Silver Nanoparticles
Author
Palomino, Luis 1   VIAFID ORCID Logo  ; Danae A Chipoco Haro 2   VIAFID ORCID Logo  ; Gakiya-Teruya, Miguel 2 ; Zhou, Feng 3   VIAFID ORCID Logo  ; Adolfo La Rosa-Toro 4   VIAFID ORCID Logo  ; Krishna, Vijay 3 ; Rodriguez-Reyes, Juan Carlos F 5   VIAFID ORCID Logo 

 Laboratory of Nanoscience and Applications—NASCA, Universidad de Ingenieria y Tecnologia—UTEC, 165 Medrano Silva, Barranco, Lima 15063, Peru; Centro de Investigacion en Bioingenieria—BIO, Universidad de Ingenieria y Tecnologia—UTEC, 165 Medrano Silva, Barranco, Lima 15063, Peru 
 Laboratory of Nanoscience and Applications—NASCA, Universidad de Ingenieria y Tecnologia—UTEC, 165 Medrano Silva, Barranco, Lima 15063, Peru 
 Department of Biomedical Engineering, Cleveland Clinic, Lerner Research Institute, Cleveland, OH 44106, USA 
 Laboratorio de Investigacion de Electroquimica Aplicada, Facultad de Ciencias, Universidad Nacional de Ingenieria, Av. Tupac Amaru 210, Rimac, Lima 15333, Peru 
 Laboratory of Nanoscience and Applications—NASCA, Universidad de Ingenieria y Tecnologia—UTEC, 165 Medrano Silva, Barranco, Lima 15063, Peru; Centro de Investigacion en Bioingenieria—BIO, Universidad de Ingenieria y Tecnologia—UTEC, 165 Medrano Silva, Barranco, Lima 15063, Peru; Department of Chemical Engineering, Universidad de Ingeniería y Tecnología—UTEC, 165 Medrano Silva, Barranco, Lima 15063, Peru 
First page
3321
Publication year
2022
Publication date
2022
Publisher
MDPI AG
e-ISSN
20794991
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2724275503
Copyright
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.